Synthesis, solution conformation, and antibody recognition of oligotuftsin-based conjugates containing a β-amyloid(4-10) plaque-specific epitope

Bioconjugate Chemistry

Volumn 16, Issue 4, 2005, Pages 921-928

  Manea, Marilena ^a   Hudecz, Ferenc ^b,c   Przybylski, Michael ^a   Mezõ, Gábor ^b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELLS; CIRCULAR DICHROISM SPECTROSCOPY; CYTOLOGY; EPITOPES; GLYCOPROTEINS; MONOCLONAL ANTIBODIES; NEURODEGENERATIVE DISEASES;

ALZHEIMERS DISEASE; ANTIBODY RECOGNITION; B CELLS; CELL EPITOPES; EPITOPE PEPTIDE; OLIGOPEPTIDES; SOLUTION CONFORMATIONS; SYNTHESIS SOLUTION; TRANSGENICS; Β-ALANINE;

PEPTIDES;

ALANINE DERIVATIVE; AMIDE; AMYLOID BETA PROTEIN[1-40]; ANTIBODY; ANTIGEN; ANTISERUM; BETA ALANINE; DIMER; EPITOPE; MONOCLONAL ANTIBODY; OLIGOPEPTIDE; TUFTSIN DERIVATIVE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CIRCULAR DICHROISM; COMPARATIVE STUDY; CONJUGATE; CONJUGATION; DRUG CONFORMATION; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; IMMUNOGENICITY; IMMUNOTHERAPY; STRUCTURE ACTIVITY RELATION; TRANSGENIC MOUSE;

EID: 22644434561     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0500037     Document Type: Article

References (34)

1. Shenk, D. (2002) Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nature Rev. Neurosci. 3, 824-828.
2. Monsonego, A., and Weiner, L. H. (2003) Immunotherapeutic approaches to Alzheimer's disease. Science 302, 834-838.
3. Selkoe, D. J., and Schenk, D. (2003) Alzheimer's disease: Moleular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545-584.
4. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Zhenmei, L., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
5. Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., Mount, H. T., Nixon, R. A., Mercken, M., Bergeron, C., Fraser, P. E., St George-Hyslop, P., and Westaway, D. (2000) Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982.
6. Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M., and Arendash, G. W. (2000) Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985.
7. Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C.; Issazadeh, S., Hancock, W. W., and Selkoe, D. J. (2000) Nasal administration of amyloid β-peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48, 567-579.
8. Check, E. (2002) Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462.
9. Nicoll, A. R. J., Wilkinson, D., Holmes, C., Steart, P., Markham H, and Weller, R. O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nature Med. 9, 448-452.
10. Sigurdsson, E. M., Scholtzova H., Mehta D. P., Frangione B., and Wisniewski T. (2001) Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease associated pathology in transgenic mice. Am. J. Pathol. 159, 439-447.
11. Macht, M., Fiedler, W., Kurzinger, K., and Przybylski, M. (1996) Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T. Biochemistry 35, 15633-15639.
12. McLaurin, J., Cecal, R., Kierstead, M. E., Tian, X., Phinney, A. L., Manea, M., French, J. E., Lambermon, M. H., Darabie, A. A., Brown, M. E., Janus, C., Chishti, M. A., Home, P., Westaway, D., Fraser, P. E., Mount, H. T., Przybylski, M., and St George-Hyslop, P. (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nature Med. 8, 1263-1269.
13. Przybylski, M., McLaurin, J., Cecal, R. E., Kierstead, M. E., Tian, X., Janus, C., Manea, M., Horne, P., Westaway, D., Fraser, P. E., and St George-Hyslop, P. (2002) Lead structures for active immunization against Alzheimer's disease (AD) upon elucidation of a plaque-specific epitope recognized by therapeutically active antisera from transgenic AD mice. Peptides 2002 (Benedetti, E., and Pedone, C., Eds.) pp 862-863, Edizioni Zino, Napoli, Italy.
14. Cecal, R., McLaurin, J., Tian, X., Manea, M., Janus, C., Westaway, D., Fraser, P., St George-Hyslop, P., and Przybylski, M. (2002) Mass spectrometric elucidation of an amyloid plaque-specific epitope: molecular basis for probing the protheolytic degradation mechanism of Alzheimer's amyloid precursor protein APP. Peptides 2002 (Benedetti, E., and Pedone, C., Eds.) pp 700-701, Edizioni Zino, Napoli, Italy.
15. Bard, F., Barbour, R., Cannon, C., Carretto, R., Fox, M., Games, D., Guido, T., Hoenow, K., Hu, K., Johnos-Wood, K., Khan, K., Kholodenko, D., Lee, C., Lee, M., Motter, R., Nguyen, M., Reed, A., Shenk, D., Tang, P., Vasqzez, N., Seubert, P., and Yednock, T. (2003) Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci. U.S.A. 100, 2023-2028.
16. Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K, Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., and Yednock, T. (2000) Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a model of Alzheimer disease. Nature Med. 6, 916-920.
17. DeMattos, R. B., Bales, R. K., Cummins, D. J., Dodart, J. K., Paul, S. M., and Holzman, D. M. (2001) Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 98, 8850-8855.
18. Purcell, A. W., Zeng, W., Mifsud, N. A., Ely, L. K., MacDonald, W. A., and Jackson, D. C. (2003) Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design. J. Pept. Sci. 9, 255-281.
19. Hudecz, F. (2001) Manipulation of epitope function by modification of peptide structure: a minireview. Biologicals 29, 197-207.
20. Wilkinson, K. A., Vordermeier, M. H., Kajtar, J., Jurcevic, S., Wilkinson, R., Ivanyi, J., and Hudecz, F. (1997) Modulation of peptide specific T cell responses by non-native flanking regions. Mol. Immunol. 34, 1237-1246.
21. Schutze, M. P., Leclerc, C., Jolivet, M., Audibert, F., and Chedid, L. (1985) Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol. 135, 2319-2322.
22. Sakata, S., and Atassi, Z. (1981) Immune recognition of serum albumin- -XIII. Autoreactivity with rabbit serum albumin of rabbit antibodies against bovine or human serum albumins and autoimmune recognition of rabbit serum albumin. Mol. Immunol. 18, 961-967.
23. Herzenberg, L. A., Tokuhisa, T., Herzenberg, L. A. (1980) Carrier-priming leads to hapten-specific suppression. Nature 285, 664-667.
24. Hudecz, F., Votavova, H., Gaál, D., Sponar, J., Kajtár, J., Blaha, K., and Szekerke, M. (1985) Branched polypeptides with poly(L-lysine) backbone: synthesis conformation and immunomodulation. Polymeric Materials in Medication (Gebelein, Ch. G.; Carraher, Ch. E.) pp 263-289, Plenum Press, New York.
25. Tam, J. P. (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U.S.A. 85, 5409-5413.
26. Trudelle, Y., Bracks, A., Delmas, A., Pedoussant, S., and Rivaille, P. (1987) Synthesis of new carrier for immunization: polytuftsin. Int. J. Pept. Protein Res. 30, 54-56.
27. Tsikaris, V., Sakarellos, C., Cung, M. T., Marraud, M., and Sakarellos-Daitiotis, M. (1996) Concept and design of a new class of sequential oligopeptide carriers (SOC) for covalent attachment of multiple antigenic peptides. Biopolymers 38, 291-293.
28. Manea, M., Mezõ, G., Hudecz, F., and Przybylski, M. (2004) Conjugates containing a b-amyloid plaque specific epitope as lead structure for vaccines against Alzheimer's disease. Biopolymers 76, 503-511.
29. Mezõ, G., Kalászi, A., Reményi, J., Majer, Zs., Hilbert, Á., Láng, O., Kõhidai, L., Barna, K., Gaál, and D., Hudecz, F. (2004) Synthesis, conformation and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence. Biopolymers 73, 645-656.
30. Fridkin, M., and Najjar, V. A. (1989) Tuftsin: its chemistry, biology, and clinical potential. Crit. Rev. Biochem. Mol. Biol. 24, 1-40.
31. Siemion IZ, and Kluczyk A. (1999) Tuftsin: on the 30-year anniversary of Victor Najjar's discovery. Peptides 20, 645-674.
32. Damoc, E., Youhnovski, N., Crettaz, D., Tissot, J. D., and Przybylski, M. (2003) High-resolution proteome analysis of cryoglobulins using Fourier transform-ion cyclotron resonance mass spectrometry. Proteomics 3, 1425-1433.
33. Rossier, J. S., Youhnovski, N., Lion, N., Damoc, E., Reymond, F., Girault, H. H., and Przybylski, M. (2003) Thin-chip microspray system for high-performance Fourier transform ion-cyclotron resonance mass spectrometry of biopolymers. Angew. Chem., Int. Ed. 42, 53-58.
34. Buck, M. (1998) Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 31, 297-355.